Exploring Targeted Therapies for Advancing Endometrial Cancer Treatment
Advancements in targeted therapies, including immune checkpoint inhibitors, antibody-drug conjugates, and drugs targeting replication stress, are transforming the treatment landscape for patients with advanced or recurrent endometrial cancer.